Photonova Spectra has achieved CE Mark. ✅ Following U.S. FDA 510(k) clearance and Japanese regulatory approval, this milestone expands access to our photon-counting CT with proprietary Deep Silicon detector technology across CE Mark–observing countries. For care teams navigating rising volumes and growing diagnostic complexity, it's engineered to deliver clarity and efficiency in the same scan.
Big milestone for GE HealthCare. The choice to use Deep Silicon instead of Cadmium Telluride (CdTe) is what makes Photonova Spectra really interesting from a BME perspective.
Congratulations to the team. What stands out to me in this image is how much thought has gone into the patient's experience during the scan — the openness of the space, the positioning, the overall sense of calm. Details like this often go unnoticed next to the technical milestones, but they matter just as much
Achieving CE Mark clearance for photon-counting CT featuring Deep Silicon technology is a game-changer for high-definition imaging and tissue characterization. At MARS Healthcare US, we applaud innovations that remove operational friction while empowering clinicians with actionable, single-scan clarity.
It’s interesting to see how much more capability is being built into advanced imaging systems. As these technologies become more sophisticated, the infrastructure supporting them becomes an important part of the overall planning as well. From GE HealthCare’s experience, are facilities considering those requirements earlier when planning for new imaging technology? GE HealthCare
The future of precision medicine depends on equally advanced diagnostic tools. Congratulations on reaching this milestone and continuing to push the boundaries of imaging innovation.
Exciting milestone for GE HealthCare. Congratulations to the team on achieving CE Mark for Photonova Spectra. Looking forward to seeing how this technology advances diagnostic imaging and clinical workflows.
Congratulations on achieving CE Mark for Photonova Spectra. Expanding access to photon‑counting CT with Deep Silicon detector technology is a major step toward clarity and efficiency in diagnostic imaging workflows.
Every time you announce something the stock price drops.
What I find interesting is the pace of innovation across the portfolio. It’s not just about introducing new technology, but continuing to move it through regulatory approval and toward real clinical use.